| 000 | 00926 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250515061341.0 | ||
| 264 | 0 | _c20070329 | |
| 008 | 200703s 0 0 eng d | ||
| 022 | _a1470-2045 | ||
| 024 | 7 |
_a10.1016/s1470-2045(07)70062-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSenior, Kathryn | |
| 245 | 0 | 0 |
_aGenetic explanation for cisplatin-induced ear damage. _h[electronic resource] |
| 260 |
_bThe Lancet. Oncology _cMar 2007 |
||
| 300 |
_a195 p. _bdigital |
||
| 500 | _aPublication Type: News | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aCisplatin _xadverse effects |
| 650 | 0 | 4 |
_aEar Diseases _xchemically induced |
| 650 | 0 | 4 |
_aGlutathione S-Transferase pi _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMutation |
| 773 | 0 |
_tThe Lancet. Oncology _gvol. 8 _gno. 3 _gp. 195 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1470-2045(07)70062-1 _zAvailable from publisher's website |
| 999 |
_c16910324 _d16910324 |
||